Medivation Company slow down as it is reported that Medivation downgraded to Hold at Roth Capita lowered to $10 .

MDVN stock condition is almost not satisfactory. Medivation is decreased 69.81% to $12.15 in the time period of pre-market session after Pfizer and Medivation Company announced results in two parts and 3 trials of the investigational drug dimebon in patients with Alzheimer’s disease. MDVN has gained over 60% in the last six months. Its time to work hard.

Medivation inc mdvn was working with their supper ambitions. Vision China Media company tumbled 29% to $5.82 in the time period of pre-market session after Vision China Media that was reported on yesterday a fourth quarter net income of $5.63 million or $0.08 per share from $14.82 million or $0.20 per share for the same quarter last year. That was closed at $8.20 in the last trading session. The 52-week trading range for VISN is $4.80 – $12.27.